• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Clinical Trial Registry Accuracy and Maintenance in ALS/MND Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • Masitinib
      • NurOwn
      • CNM-Au8
      • ILB
      • AstroRx
      • Neuronata-R / Lenzumestrocel
      • PrimeC
      • NP001
      • Pridopidine
      • SOD1 Therapies and Trials
      • C9orf72 Therapies and Trials
      • SPG302
      • Regulatory T Cell Enhancing Therapies
      • Ulefnersen
    • Approved Drugs
      • Nuedexta
      • Radicava / Edaravone
      • Riluzole / Tiglutik
      • Rozebalamin / Methylcobalamin
      • Tofersen / Qalsody
    • Drugs No Longer in Development
      • AMX0035
      • Reldesemtiv
      • Arimoclomol
      • TUDCA
      • CuATSM
  • Support for Health Professionals
    • Breaking the News in ALS/MND
    • R.A.C.E. to Diagnose ALS/MND
  • Programs & Events
    • Calendar of Events
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

Forbes Norris Award

The Forbes Norris Award was established in 1994 to honour the legacy of Dr. Forbes “Ted” Norris (1928–1993), a neurologist who dedicated his life to supporting people living with ALS/MND. This prestigious award recognizes individuals whose work advances clinical care, research, and understanding of ALS/MND for the benefit of those living with the disease.

To be considered for the Forbes Norris Award, candidates must:

  • Play a major role in delivering outstanding ALS/MND patient care
  • Contribute significantly to medical literature in clinical management or basic science related to ALS/MND
  • Be part of a team engaged in ongoing research into ALS/MND care, management, or basic science

The award is presented annually during the opening ceremony of the MND Association’s International Symposium on ALS/MND. If no suitable candidate is nominated in a given year, the award will not be granted. Please note that current Board of Directors are not eligible for nomination.

The 2026 nomination period is open. The deadline to submit your nominations is Tuesday, September 22.

Forbes Norris Award Nomination Form

  • (No self-nominations please)
  • Accepted file types: doc, docx, pdf, Max. file size: 128 MB.
    Please use .doc, .docx, or .pdf
  • This field is for validation purposes and should be left unchanged.

Primary Sidebar

  • Carlos Alberto Arango, Colombia

    Carlos Alberto Arango, Colombia

  • John Dinon, Australia

    John Dinon, Australia

  • Joy Blakeley, Australia

    Joy Blakeley, Australia

  • Josée Kolijn-de Man, Netherlands

    Josée Kolijn-de Man, Netherlands

  • Ian Gale, Australia

    Ian Gale, Australia

  • Phil Rossall, UK

    Phil Rossall, UK

  • Zabun Nassar, England

    Zabun Nassar, England

  • Margreth Burger-Saile, Switzerland

    Margreth Burger-Saile, Switzerland

  • JP

    JP

  • Juvenal Bayona Romero, Colombia

    Juvenal Bayona Romero, Colombia

  • Sanjay Kumar Srivastava, India

    Sanjay Kumar Srivastava, India

  • Ywan Dierick, Belgium

    Ywan Dierick, Belgium

  • Animesh Kumar, India

    Animesh Kumar, India

  • Armando González Gómez, Colombia

    Armando González Gómez, Colombia

  • Fabio Carvalho, Brazil

    Fabio Carvalho, Brazil

  • Diana Fernandez, Argentina

    Diana Fernandez, Argentina

  • Eddy Lefrancois, Canada

    Eddy Lefrancois, Canada

  • Willi Klein, UK

    Willi Klein, UK

  • Bjarne Hytjanstorp, Norway

    Bjarne Hytjanstorp, Norway

  • Eddy LeFrançois, Canada

    Eddy LeFrançois, Canada

  • Mark Miller, UK

    Mark Miller, UK

  • Alex, Argentina

    Alex, Argentina

  • Guido De Mets, Belgium

    Guido De Mets, Belgium

  • Chen Chun-Chin, Malaysia

    Chen Chun-Chin, Malaysia

  • Rolf Mauch, Switzerland

    Rolf Mauch, Switzerland

  • Chih Ching Darren Wong, Malaysia

    Chih Ching Darren Wong, Malaysia

  • David Bishop, UK

    David Bishop, UK

  • Claudia Gotti, Brazil

    Claudia Gotti, Brazil

  • Sally Pauls, USA

    Sally Pauls, USA

  • Mauril Bélanger, Canada

    Mauril Bélanger, Canada

  • Maria Lucia Wood Saldanha, Brazil

    Maria Lucia Wood Saldanha, Brazil

  • PALS and CALS, Singapore

    PALS and CALS, Singapore

  • Duncan Bayly, Australia

    Duncan Bayly, Australia

  • Cliff Marshman, USA

    Cliff Marshman, USA
    CliffMarshman

  • Mauricio Dorin, Argentina

    Mauricio Dorin, Argentina

  • Anna Barrow, UK

    Anna Barrow, UK

  • Chirag Walia, India

    Chirag Walia, India
    ChiragWalia

  • Andres Estevez Guersznik, Ireland

    Andres Estevez Guersznik, Ireland

  • Hanne Stenmose, Denmark

    Hanne Stenmose, Denmark

  • Len Johnrose, England

    Len Johnrose, England

  • Chen Yin Xue, Taiwan

    Chen Yin Xue, Taiwan

  • Barry de Reuver, Netherlands

    Barry de Reuver, Netherlands

  • Lineke Veenstra, Netherlands

    Lineke Veenstra, Netherlands

  • Peng Yi-Wen, Taiwan

    Peng Yi-Wen, Taiwan

  • Joyce Rusinak, USA

    Joyce Rusinak, USA

  • Yessenia Hernandez Mendoza, Mexico

    Yessenia Hernandez Mendoza, Mexico

  • Maurice Leclerc, Canada

    Maurice Leclerc, Canada

  • Kris Van Reusel, Belgium

    Kris Van Reusel, Belgium

  • Andrea Zicchieri, Italy

    Andrea Zicchieri, Italy
    AndreaZicchieri_conSLAncioItaly

  • Susan Anderson, USA

    Susan Anderson, USA

Learn more about the March of Faces

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login